In this section, we noticed that different types of KRAS mutated variants associated with different types of cancer influence the pathogenicity and regulate other factors, namely tumor-suppressive factors, cell-cycle regulators, and immune-response factors. This evidence concerns the gene KRAS and neoplasm.